Israeli cannabis start-up launches exciting new product

Medical cannabis company, Medican Pharma, recently launched Allegro, a new product from the SEVEN cannabis brand series. This is medical cannabis grown under controlled and optimal conditions.

An employee checks cannabis plants at a medical marijuana plantation in northern Israel March 21, 2017 (photo credit: REUTERS/NIR ELIAS)
An employee checks cannabis plants at a medical marijuana plantation in northern Israel March 21, 2017
(photo credit: REUTERS/NIR ELIAS)

The Medican Group, led by brothers Assaf and Tal Sela, is a fourth-generation family business to work in agriculture and innovation. The brothers brought a new industry to the business when they entered the field of medical cannabis.

It all started because their grandmother was diagnosed with dementia and began treatment with medical cannabis.

Witnessing the cannabis revolution 

Over the years of treatment and after witnessing its transformative effects, the family began to research, study and explore methods to ensure the complete maintenance of safety, uniformity and quality to allow patient adherence to a therapeutic sequence of medical cannabis products.

Sela explained that overcrowding plants, weather fluctuations, poor growing environment, poor sanitation along with lack of care for the drying and aging processes can cause mold, fungi, and poor quality medical cannabis.

The company recently launched a new product, Allegro, from the cannabis brand series SEVEN. This is an ultra-premium level medical cannabis, grown under controlled and optimal conditions. The cultivation was done at a facility that the company established in the central area for the growth and harvesting of medical cannabis.

Hundreds of Israelis gather in Rabin Square in Tel Aviv on April 20, 2021to protest in favor of cannabis legalization and for reforms in the medical cannabis market. (credit: AVSHALOM SASSONI/ MAARIV)Hundreds of Israelis gather in Rabin Square in Tel Aviv on April 20, 2021to protest in favor of cannabis legalization and for reforms in the medical cannabis market. (credit: AVSHALOM SASSONI/ MAARIV)

This facility is a unique combination of hi-tech, agro-tech and pharma-tech. It’s a clean, closed and completely controlled environment which allows for optimal care for product safety, without using pesticides, able to maintain the concentration of active ingredients of the plants at the maximum levels and evenly throughout the various growth cycles.

The company distributes its products through Madison Pharma and participates in clinical trials.

The medical cannabis market is growing in Israel, one of the first countries in the world to approve its use, along with the USA, Canada and Germany.

The market in Israel is measured by the number of patients and licenses issued by the Health Ministry.

Since February, over 62,000 licenses have been granted patients in chronic pain, over 13,000 for cancer patients, and over 12,000 for psychiatric cases.

What does Medican bring to the table?

Medican strives to grow the safest and highest quality medical cannabis out of a commitment to the public and while meeting the most stringent regulatory requirements. The company aims to produce medical cannabis with a strong emphasis on safety, quality and freshness at the highest levels.

“At Medican, we place the patient at the center and invest a lot of effort and resources to ensure a therapeutic sequence for the product, while maintaining a maximum level of uniformity of the entire concentration of active ingredients between batches,” Sela emphasizes.